WO2002007760A3 - Therapeutic agent against aids comprising anti hiv goat antibody - Google Patents
Therapeutic agent against aids comprising anti hiv goat antibody Download PDFInfo
- Publication number
- WO2002007760A3 WO2002007760A3 PCT/GB2001/003292 GB0103292W WO0207760A3 WO 2002007760 A3 WO2002007760 A3 WO 2002007760A3 GB 0103292 W GB0103292 W GB 0103292W WO 0207760 A3 WO0207760 A3 WO 0207760A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- therapeutic agent
- agent against
- goat antibody
- anti hiv
- against aids
- Prior art date
Links
- 241000283707 Capra Species 0.000 title abstract 2
- 230000036436 anti-hiv Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 3
- 208000030507 AIDS Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001275696A AU2001275696A1 (en) | 2000-07-21 | 2001-07-20 | Therapeutic agent |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21991000P | 2000-07-21 | 2000-07-21 | |
US60/219,910 | 2000-07-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002007760A2 WO2002007760A2 (en) | 2002-01-31 |
WO2002007760A3 true WO2002007760A3 (en) | 2002-04-18 |
Family
ID=22821237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/003292 WO2002007760A2 (en) | 2000-07-21 | 2001-07-20 | Therapeutic agent against aids comprising anti hiv goat antibody |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001275696A1 (en) |
WO (1) | WO2002007760A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL159682A0 (en) * | 2001-07-02 | 2004-06-20 | Aimsco Ltd | Use of polyclonal anti-hiv goat serum as a therapeutic agent |
GB0201896D0 (en) * | 2002-01-28 | 2002-03-13 | Ice Biolog Ltd | Treatment |
CA2473754C (en) * | 2002-01-28 | 2012-04-10 | Aimsco Limited | Treatment of ms with goat serum |
GB0600202D0 (en) * | 2006-01-06 | 2006-02-15 | Aimsco Ltd | Treatment of HIV |
US20180235900A1 (en) * | 2017-02-06 | 2018-08-23 | Research Triangle Institute | Subcutaneous reservoir device and method of manufacture |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995016710A1 (en) * | 1993-12-13 | 1995-06-22 | United Biomedical, Inc. | Specific hyperimmune anti-hiv globulin for passive immunization |
WO1997002839A1 (en) * | 1995-07-13 | 1997-01-30 | Gkc Research, Inc. | Viral suppression, treatment and prevention of viral infections |
-
2001
- 2001-07-20 AU AU2001275696A patent/AU2001275696A1/en not_active Abandoned
- 2001-07-20 WO PCT/GB2001/003292 patent/WO2002007760A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995016710A1 (en) * | 1993-12-13 | 1995-06-22 | United Biomedical, Inc. | Specific hyperimmune anti-hiv globulin for passive immunization |
WO1997002839A1 (en) * | 1995-07-13 | 1997-01-30 | Gkc Research, Inc. | Viral suppression, treatment and prevention of viral infections |
Non-Patent Citations (3)
Title |
---|
KARPAS A ET AL: "Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 85, no. 23, December 1988 (1988-12-01), pages 9234 - 9237, XP002158689, ISSN: 0027-8424 * |
KUDOYAROVA-ZUBAVICHENE N M ET AL: "PREPARATION AND USE OF HYPERIMMUNE SERUM FOR PROPHYLAXIS AND THERAPY OF EBOLA VIRUS INFECTIONS", JOURNAL OF INFECTIOUS DISEASES, CHICAGO, IL, US, vol. 179, no. SUPPL 1, February 1999 (1999-02-01), pages S218 - S223, XP000979167, ISSN: 0022-1899 * |
PALKER T ET AL: "Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 142, no. 10, 15 May 1989 (1989-05-15), pages 3612 - 3619, XP002158688, ISSN: 0022-1767 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002007760A2 (en) | 2002-01-31 |
AU2001275696A1 (en) | 2002-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001068117A3 (en) | Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
WO2003051306A3 (en) | N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections | |
WO2001095899A3 (en) | Pharmaceutical compositions comprising cannabidiol derivatives | |
EA200201263A1 (en) | METHODS OF TREATING INFECTIONS, CAUSED BY THE HEPATITIS DELTA VIRUS, USING β-L-2'-DEOXYNUCLEOSIDES | |
EE05442B1 (en) | A low dose entecavir pharmaceutical composition for the treatment of hepatitis B virus infection and a method for its preparation | |
TW371628B (en) | Composition for treating condyloma acuminata | |
WO2002000242A8 (en) | Human papilloma virus treatment | |
WO2004107956A3 (en) | Methods and devices for the treatment of skin lesions | |
NZ515392A (en) | Respiratory syncytial virus replication inhibitors | |
WO2006044968A3 (en) | Combination therapy for treating viral infections | |
WO2001010456A3 (en) | Peptides that block viral infectivity and methods of use thereof | |
WO2002028426A8 (en) | Split enveloped virus preparation | |
AU1167602A (en) | Methods of therapy for hiv infection | |
WO2003059385A3 (en) | Hiv vaccine and method of use | |
WO2004026260A3 (en) | Prophylactic and therapeutic hiv aptamers | |
WO2003004049A3 (en) | Use of polyclonal anti-hiv goat serum as a therapeutic agent | |
WO2005089231A3 (en) | Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide | |
AU2002219881A1 (en) | Methods and compositions for the treatment of human immunodeficiency virus infection | |
WO2005097618A3 (en) | Low dose therapy for treating viral infections | |
WO2002007760A3 (en) | Therapeutic agent against aids comprising anti hiv goat antibody | |
AU2003217604A8 (en) | Method of treating hiv infection by preventing interaction of cd4 and gp120 | |
WO2001010454A3 (en) | Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection | |
EP1283040A4 (en) | Sustained release oral preparations | |
WO1997026880A3 (en) | Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |